Synthesis, Characterization and Biological Activity of Some Dithiourea Derivatives. 2020

Felix Odame, and Eric Hosten, and Jason Krause, and Michelle Isaacs, and Heinrich Hoppe, and Setshaba D Khanye, and Yasien Sayed, and Carminita Frost, and Kevin Lobb, and Zenixole Tshentu

Novel dithiourea derivatives have been designed as HIV-1 protease inhibitors using Autodock 4.2, synthesized and characterized by spectroscopic methods and microanalysis. 1-(3-Bromobenzoyl)-3-[2-([(3-bromophenyl)formami-do]methanethioylamino)phenyl]thiourea (10) and 3-benzoyl-1[(phenylformamido)methanethioyl]aminothiourea (12) gave a percentage viability of 17.9 ± 5.6% and 11.2 ± 0.9% against Trypanosoma brucei. Single crystal X-ray dif-fraction analysis of 1-benzoyl-3-(5-methyl-2-[(phenylformamido)methanethioyl]aminophenyl)thiourea (1), 3-ben-zoyl-1-(2-[(phenylformamido)methanethioyl]aminoethyl)thiourea (11), 3-benzoyl-1-[(phenylformamido)methan-ethioyl]aminothiourea (12) and 3-benzoyl-1-(4-[(phenylformamido)methanethioyl]aminobutyl)thiourea (14) have been presented. 1-(3-Bromobenzoyl)-3-[2-([(3-bromophenyl)formamido]methanethioylamino)phenyl]thiourea (10) gave a percentage inhibition of 97.03 ± 0.37% against HIV-1 protease enzyme at a concentration of 100 ?M.

UI MeSH Term Description Entries

Related Publications

Felix Odame, and Eric Hosten, and Jason Krause, and Michelle Isaacs, and Heinrich Hoppe, and Setshaba D Khanye, and Yasien Sayed, and Carminita Frost, and Kevin Lobb, and Zenixole Tshentu
October 2011, Pakistan journal of pharmaceutical sciences,
Felix Odame, and Eric Hosten, and Jason Krause, and Michelle Isaacs, and Heinrich Hoppe, and Setshaba D Khanye, and Yasien Sayed, and Carminita Frost, and Kevin Lobb, and Zenixole Tshentu
July 1965, Journal of pharmaceutical sciences,
Felix Odame, and Eric Hosten, and Jason Krause, and Michelle Isaacs, and Heinrich Hoppe, and Setshaba D Khanye, and Yasien Sayed, and Carminita Frost, and Kevin Lobb, and Zenixole Tshentu
September 1996, Bollettino chimico farmaceutico,
Felix Odame, and Eric Hosten, and Jason Krause, and Michelle Isaacs, and Heinrich Hoppe, and Setshaba D Khanye, and Yasien Sayed, and Carminita Frost, and Kevin Lobb, and Zenixole Tshentu
January 2023, Current organic synthesis,
Felix Odame, and Eric Hosten, and Jason Krause, and Michelle Isaacs, and Heinrich Hoppe, and Setshaba D Khanye, and Yasien Sayed, and Carminita Frost, and Kevin Lobb, and Zenixole Tshentu
January 2009, Acta poloniae pharmaceutica,
Felix Odame, and Eric Hosten, and Jason Krause, and Michelle Isaacs, and Heinrich Hoppe, and Setshaba D Khanye, and Yasien Sayed, and Carminita Frost, and Kevin Lobb, and Zenixole Tshentu
January 2005, Arzneimittel-Forschung,
Felix Odame, and Eric Hosten, and Jason Krause, and Michelle Isaacs, and Heinrich Hoppe, and Setshaba D Khanye, and Yasien Sayed, and Carminita Frost, and Kevin Lobb, and Zenixole Tshentu
January 1988, Il Farmaco; edizione scientifica,
Felix Odame, and Eric Hosten, and Jason Krause, and Michelle Isaacs, and Heinrich Hoppe, and Setshaba D Khanye, and Yasien Sayed, and Carminita Frost, and Kevin Lobb, and Zenixole Tshentu
January 1977, Pharmaceutica acta Helvetiae,
Felix Odame, and Eric Hosten, and Jason Krause, and Michelle Isaacs, and Heinrich Hoppe, and Setshaba D Khanye, and Yasien Sayed, and Carminita Frost, and Kevin Lobb, and Zenixole Tshentu
May 1990, Journal of medicinal chemistry,
Felix Odame, and Eric Hosten, and Jason Krause, and Michelle Isaacs, and Heinrich Hoppe, and Setshaba D Khanye, and Yasien Sayed, and Carminita Frost, and Kevin Lobb, and Zenixole Tshentu
December 2018, Acta chimica Slovenica,
Copied contents to your clipboard!